ArticleHaematologica2025

Venetoclax combined with escalating doses of homoharringtonine, low-dose cytarabine, and granulocyte colony-stimulating factor demonstrates feasibility and tolerability for remission induction in pediatric acute myeloid leukemia.

Shengqin Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.